Taysha Gene Therapies Inc. (TSHA) Social Stream



Taysha Gene Therapies Inc. (TSHA): $1.84

0.08 (+4.55%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add TSHA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#312 of 345

in industry

TAYSHA GENE THERAPIES INC (TSHA) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering TSHA.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-10 11 $60 $34 $45.6 $1.82 2405.49%
2021-11-11 11 $60 $33 $44.9 $1.82 2367.03%
2022-01-27 12 $60 $28 $43.363 $1.82 2282.58%
2022-01-31 12 $60 $28 $42.545 $1.82 2237.64%
2022-03-01 13 $60 $25 $41.083 $1.82 2157.31%
2022-03-09 14 $60 $25 $39.923 $1.82 2093.57%
2022-04-04 14 $45 $22 $32.923 $1.82 1708.96%
2022-05-17 14 $45 $22 $32.076 $1.82 1662.42%
2022-05-19 14 $45 $9 $30.846 $1.82 1594.84%
2022-05-24 15 $45 $9 $29.785 $1.82 1536.54%
2022-08-12 11 $38 $9 $26.272 $1.82 1343.52%
2022-08-15 10 $38 $16 $27.8 $1.82 1427.47%
2022-10-26 10 $38 $15 $24.4 $1.82 1240.66%
2022-11-08 11 $38 $15 $23.636 $1.82 1198.68%
2022-11-09 11 $38 $15 $22.909 $1.82 1158.74%
2022-11-14 12 $23 $3 $16.083 $1.82 783.68%
2022-12-21 12 $24 $3 $16.692 $1.82 817.14%
2023-01-04 12 $24 $3 $16.384 $1.82 800.22%
2023-01-30 12 $24 $3 $14.846 $1.82 715.71%
2023-02-01 13 $19 $1.5 $7.961 $1.82 337.42%
2023-03-29 12 $19 $1.5 $7.961 $1.82 337.42%
2023-03-30 12 $19 $0.7 $6.746 $1.82 270.66%
2023-05-12 11 $19 $0.7 $7.225 $1.82 296.98%
2023-08-15 11 $19 $2 $8 $1.82 339.56%
2023-08-16 11 $19 $2 $7.666 $1.82 321.21%
2023-09-20 11 $19 $2 $7.333 $1.82 302.91%
2023-09-21 11 $19 $2 $7.25 $1.82 298.35%
2023-10-24 10 $19 $2 $7.409 $1.82 307.09%
2023-11-15 10 $8 $2 $5.5 $1.82 202.2%
2023-11-16 10 $7.5 $2 $5.5 $1.82 202.2%

The Trend in the Analyst Price Target


TSHA's average price target has moved down $11.19 over the prior 47 weeks.

TSHA reports an average of 556.35% for its upside potential over the past 47 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-01 12 19.0 1.5 7.961 1.210 557.93%
2023-03-30 12 19.0 0.7 6.746 0.724 831.77%
2023-09-21 11 19.0 2.0 7.636 3.030 152.01%
2023-09-21 10 19.0 2.0 7.636 3.030 152.01%
2023-11-15 10 7.5 2.0 5.388 1.680 220.71%

TSHA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 7 1 2 0 0 10

The Trend in the Broker Recommendations


Over the past 23 months, TSHA's average broker recommendation rating worsened by 0.33.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for TSHA as an investment opportunity.

  • In terms of how TAYSHA GENE THERAPIES INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 4032.49% of that group.
  • TSHA has a lower variance in analysts' estimates than -3791.26% of all US stocks.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, TAYSHA GENE THERAPIES INC's number of analysts covering the stock is higher than 4238.49% of them.
  • To contextualize these metrics, consider that out of stocks in the small market cap category, TAYSHA GENE THERAPIES INC's average analyst price target is higher than 2089.98% of them.

Stocks similar to TAYSHA GENE THERAPIES INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are OPT, TARS, and ALGS.

Make investment decisions regarding TSHA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!